347 related articles for article (PubMed ID: 26063231)
1. Mesenchymal stem cells for therapeutic applications in pulmonary medicine.
Stabler CT; Lecht S; Lazarovici P; Lelkes PI
Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231
[TBL] [Abstract][Full Text] [Related]
2. Cell-based therapies for lung disease.
Garcia O; Carraro G; Navarro S; Bertoncello I; McQualter J; Driscoll B; Jesudason E; Warburton D
Br Med Bull; 2012; 101(1):147-61. PubMed ID: 22279079
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cell trials for pulmonary diseases.
Antunes MA; Laffey JG; Pelosi P; Rocco PR
J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy for acute respiratory distress syndrome: a promising future?
Horie S; Masterson C; Devaney J; Laffey JG
Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair.
Huang S; Lu G; Wu Y; Jirigala E; Xu Y; Ma K; Fu X
J Dermatol Sci; 2012 Apr; 66(1):29-36. PubMed ID: 22398148
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases.
Sadeghian Chaleshtori S; Mokhber Dezfouli MR; Jabbari Fakhr M
Respir Res; 2020 May; 21(1):110. PubMed ID: 32393278
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells and inflammatory lung diseases.
Iyer SS; Co C; Rojas M
Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
[TBL] [Abstract][Full Text] [Related]
8. Stem cell therapy in pulmonary fibrosis.
Tzouvelekis A; Antoniadis A; Bouros D
Curr Opin Pulm Med; 2011 Sep; 17(5):368-73. PubMed ID: 21681099
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.
Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J
Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258
[TBL] [Abstract][Full Text] [Related]
10. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
Wang J; Liao L; Tan J
Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-mediated treatment of oral diseases.
Liu Y; Hu J; Wang S
Histol Histopathol; 2014 Aug; 29(8):1007-15. PubMed ID: 24638842
[TBL] [Abstract][Full Text] [Related]
13. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
Conese M; Carbone A; Castellani S; Di Gioia S
Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth.
Laube M; Stolzing A; Thome UH; Fabian C
Int J Biochem Cell Biol; 2016 May; 74():18-32. PubMed ID: 26928452
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model.
Ladak A; Olson J; Tredget EE; Gordon T
Exp Neurol; 2011 Apr; 228(2):242-52. PubMed ID: 21281630
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
[TBL] [Abstract][Full Text] [Related]
18. Cell therapy approaches for lung diseases: current status.
Sueblinvong V; Weiss DJ
Curr Opin Pharmacol; 2009 Jun; 9(3):268-73. PubMed ID: 19349209
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease.
Mohammadipoor A; Antebi B; Batchinsky AI; Cancio LC
Respir Res; 2018 Nov; 19(1):218. PubMed ID: 30413158
[TBL] [Abstract][Full Text] [Related]
20. Biological considerations of mesenchymal stem cells and endothelial progenitor cells.
Papathanasopoulos A; Giannoudis PV
Injury; 2008 Sep; 39 Suppl 2():S21-32. PubMed ID: 18804570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
